| Nome |
# |
|
Alcolismo e anestesia, file e2f56ed4-20dd-3eaf-e053-3a05fe0a5d97
|
337
|
|
null, file e2f56ed5-19c1-3eaf-e053-3a05fe0a5d97
|
319
|
|
A systematic review of school-based alcohol and other drug prevention programs, file e2f56ed3-ca2c-3eaf-e053-3a05fe0a5d97
|
274
|
|
The use of baclofen as a treatment for alcohol use disorder: a clinical practice perspective, file e2f56ed8-2e12-3eaf-e053-3a05fe0a5d97
|
242
|
|
Unawareness of Alcoholic Content of Alcopops among 13-Year Old Italian Teenagers., file e2f56ed3-a15e-3eaf-e053-3a05fe0a5d97
|
227
|
|
null, file e2f56ed3-ca05-3eaf-e053-3a05fe0a5d97
|
221
|
|
GABAB receptor as therapeutic target for drug addiction: from baclofen to positive allosteric modulators, file e2f56ed3-b1c9-3eaf-e053-3a05fe0a5d97
|
185
|
|
null, file e2f56ed3-a258-3eaf-e053-3a05fe0a5d97
|
171
|
|
null, file e2f56ed4-181a-3eaf-e053-3a05fe0a5d97
|
164
|
|
Alcohol-medication interactions: A systematic review and meta-analysis of placebo-controlled trials, file e2f56eda-36f1-3eaf-e053-3a05fe0a5d97
|
130
|
|
null, file e2f56ed6-3f64-3eaf-e053-3a05fe0a5d97
|
126
|
|
Baclofen for the treatment of alcohol use disorder: the Cagliari statement, file e2f56ed8-0a39-3eaf-e053-3a05fe0a5d97
|
124
|
|
Use of pharmacological treatments by a sample of Italian patients affected by alcohol use disorders, file e2f56ed4-22f4-3eaf-e053-3a05fe0a5d97
|
92
|
|
Baclofen for the treatment of alcohol use disorder: the Cagliari statement, file e2f56ed7-8889-3eaf-e053-3a05fe0a5d97
|
85
|
|
null, file e2f56ed7-ae65-3eaf-e053-3a05fe0a5d97
|
77
|
|
‘Mother’s Ruin’—Why Sex and Gender Differences in the Field of Alcohol Research Need Consideration, file e2f56eda-7662-3eaf-e053-3a05fe0a5d97
|
65
|
|
Alcohol-related behaviour in freshmen university students in Sardinia, Italy, file e2f56ed9-cbbb-3eaf-e053-3a05fe0a5d97
|
62
|
|
HIV and alcohol use disorder: we cannot ignore the elephant in the room, file e2f56ed8-636d-3eaf-e053-3a05fe0a5d97
|
53
|
|
Oxytocin Nasal Spray in the Treatment of Binge Eating Disorder and Obesity: A pilot, Randomized, Double Blind Trial, file e2f56eda-64cd-3eaf-e053-3a05fe0a5d97
|
37
|
|
Editorial: Baclofen in the Treatment of Alcohol Use Disorder, file e2f56eda-8ff9-3eaf-e053-3a05fe0a5d97
|
36
|
|
Baclofen for alcohol use disorder, file 2aa723fc-70ca-4f8c-b476-457dc579df85
|
35
|
|
Sex differences in the response to opioids for pain relief: A systematic review and meta-analysis, file e2f56ed8-9528-3eaf-e053-3a05fe0a5d97
|
32
|
|
Oxytocin nasal spray in fibromyalgic patients: additional information : reply to the comment to the editor entitled "future directions for the investigation of intranasal oxytocin and pain", file e2f56eda-56eb-3eaf-e053-3a05fe0a5d97
|
27
|
|
"Acute Alcohol Intoxication", file e2f56ed5-ac09-3eaf-e053-3a05fe0a5d97
|
19
|
|
GABAB receptor as therapeutic target for drug addiction: from baclofen to positive allosteric modulators, file e2f56ed3-f776-3eaf-e053-3a05fe0a5d97
|
15
|
|
Alcohol consumption is a modifiable risk factor for breast cancer: Are women aware of this relationship?, file e2f56eda-9d49-3eaf-e053-3a05fe0a5d97
|
15
|
|
Gender Differences among Sardinians with Alcohol Use Disorder, file e2f56eda-5afd-3eaf-e053-3a05fe0a5d97
|
13
|
|
Education and Training in Alcohology in Italy, file 8623fbf3-1b1a-4694-82ba-c5c7f6e29cca
|
12
|
|
Oxytocin nasal spray in fibromyalgic patients, file e2f56ed3-be37-3eaf-e053-3a05fe0a5d97
|
12
|
|
Identifying the most important research, policy and practice questions for substance use, problematic alcohol use and behavioural addictions in autism (SABA-A): A priority setting partnership, file a65fe2db-a6e9-4538-aae9-38684bdd0eb9
|
11
|
|
Baclofen in the treatment of patients with alcohol use disorder and other mental health disorders, file e2f56eda-3425-3eaf-e053-3a05fe0a5d97
|
11
|
|
TIAMINA AI PAZIENTI CON DISTURBO DA USO DI ALCOL VISITATI IN PRONTO SOCCORSO: IN ITALIA ABBIAMO LA FORMULAZIONE ADATTA?, file 0861c32c-3086-412e-bcbf-49c760f272cf
|
10
|
|
Exposure to an enriched environment reduces alcohol self-administration in Sardinian alcohol-preferring rats, file e2f56eda-47ef-3eaf-e053-3a05fe0a5d97
|
10
|
|
GABAB receptor ligands for the treatment of alcohol use disorder: preclinical and clinical evidence., file e2f56eda-5928-3eaf-e053-3a05fe0a5d97
|
10
|
|
null, file e2f56ed3-af03-3eaf-e053-3a05fe0a5d97
|
8
|
|
Hazardous drinking and alcohol use disorders, file b1d2bb05-40e3-4790-b4ca-47147a25d83f
|
7
|
|
Use of medications for the treatment of alcohol dependence: a retrospective study conducted in 2011-2012, file e2f56ed9-d520-3eaf-e053-3a05fe0a5d97
|
7
|
|
Non-specialist health workers to treat excessive alcohol consumption and depression, file e2f56eda-6eea-3eaf-e053-3a05fe0a5d97
|
7
|
|
Combined pharmacological and psychosocial interventions for alcohol use disorder, file b7f4cd63-63ba-40ac-8cb2-1d572c845f2b
|
6
|
|
Targeting the GABAB receptor for the treatment of alcohol use disorder, file e2f56ed6-484f-3eaf-e053-3a05fe0a5d97
|
6
|
|
Antidepressants for the treatment of people with co-occurring depression and alcohol dependence, file e2f56ed7-a247-3eaf-e053-3a05fe0a5d97
|
6
|
|
Disturbo da uso di alcol e giovani, file e2f56ed8-285d-3eaf-e053-3a05fe0a5d97
|
6
|
|
Il trattamento residenziale breve delle dipendenze da alcol e cocaina: Il modello Soranzo, file e2f56ed3-a7a1-3eaf-e053-3a05fe0a5d97
|
5
|
|
null, file e2f56ed3-a88d-3eaf-e053-3a05fe0a5d97
|
5
|
|
Efficacy and Tolerability of Baclofen in Substance Use Disorders: A Systematic Review., file e2f56ed4-051b-3eaf-e053-3a05fe0a5d97
|
5
|
|
null, file e2f56ed3-a583-3eaf-e053-3a05fe0a5d97
|
4
|
|
Use of the screening suggested by the National Institute on Alcohol Abuse and Alcoholism and of a newly-derived tool for the detection of unhealthy alcohol drinkers among surgical patients, file e2f56ed3-afd8-3eaf-e053-3a05fe0a5d97
|
4
|
|
null, file e2f56ed3-b58c-3eaf-e053-3a05fe0a5d97
|
4
|
|
Le dipendenze. In: Farmacologia a cura di Stefano Govoni. Ed. Casa Editrice Ambrosiana,, file e2f56ed3-fa2c-3eaf-e053-3a05fe0a5d97
|
4
|
|
The influence of anxiety symptoms on clinical outcomes during baclofen treatment of alcohol use disorder: A systematic review and meta-analysis, file e2f56ed9-957f-3eaf-e053-3a05fe0a5d97
|
4
|
|
Alcol: nuove e vecchie frontiere, file e2f56ed9-c90c-3eaf-e053-3a05fe0a5d97
|
4
|
|
ALCOL E TUMORE ALLA MAMMELLA, file e5e597c7-735c-4767-a71d-f9a3b6804236
|
4
|
|
Alcol, salute e medicina generale (Editoriale), file e2f56ed3-b02a-3eaf-e053-3a05fe0a5d97
|
3
|
|
L'efficacia dei farmaci per l'alcolismo nella donna, file e2f56ed3-b1cb-3eaf-e053-3a05fe0a5d97
|
3
|
|
Io e l'alcolismo. I sintomi, la diagnosi, le terapie, le nuove frontiere della ricerca in un pratico libro-intervista per pazienti lettori, e non solo, file e2f56ed3-f7ea-3eaf-e053-3a05fe0a5d97
|
3
|
|
Interazioni tra alcol e farmaci: revisione sistematica della letteratura, file e2f56ed7-d481-3eaf-e053-3a05fe0a5d97
|
3
|
|
Baclofen e disturbo da uso di alcol, file e2f56ed9-dc72-3eaf-e053-3a05fe0a5d97
|
3
|
|
Psychosocial and medication interventions to stop or reduce alcohol consumption during pregnancy, file f1fde166-b004-4918-b9f3-13caa5ae1022
|
3
|
|
Helping Patients Who Drink Too Much. A Clinician's Guide, file e2f56ed3-a88e-3eaf-e053-3a05fe0a5d97
|
2
|
|
Constant absolute ethanol intake by Sardinian alcohol-preferring rats independent of ethanol concentrations, file e2f56ed3-f779-3eaf-e053-3a05fe0a5d97
|
2
|
|
Efficacy of Medications Approved for the Treatment of Alcohol Dependence and Alcohol Withdrawal Syndrome in Female Patients: A Descriptive Review, file e2f56ed5-811e-3eaf-e053-3a05fe0a5d97
|
2
|
|
Farmaci per il binge eating disorder: dagli Stati Uniti all’Europa, file e2f56ed5-85b7-3eaf-e053-3a05fe0a5d97
|
2
|
|
Alcol e prevenzione, file e2f56ed5-8e28-3eaf-e053-3a05fe0a5d97
|
2
|
|
Baclofen and alcohol in France – Authors' reply, file e2f56ed7-c168-3eaf-e053-3a05fe0a5d97
|
2
|
|
null, file e2f56ed8-0f74-3eaf-e053-3a05fe0a5d97
|
2
|
|
The Validity of the State-Trait Anxiety Inventory and the Brief Scale for Anxiety in an Inpatient Sample with Alcohol Use Disorder, file e2f56eda-2988-3eaf-e053-3a05fe0a5d97
|
2
|
|
Thiamine administration to all patients with alcohol use disorder: why not?, file e2f56eda-954a-3eaf-e053-3a05fe0a5d97
|
2
|
|
null, file e2f56eda-ce84-3eaf-e053-3a05fe0a5d97
|
2
|
|
null, file 027ef9d0-e92c-498a-aab7-4eda30439234
|
1
|
|
Interazioni tra alcol e farmaci: Revisione sistematica della letteratura e meta-analisi, file 4e6f029a-484f-403a-b0b8-6e211f4d1be6
|
1
|
|
Disulfiram for the treatment of cocaine dependence, file 7e1c7ff7-d211-4d42-9e09-ef7d995e3428
|
1
|
|
Le dipendenze, file b3b39c38-b0b1-4c62-837a-036124e969c9
|
1
|
|
The development of medication for alcohol-use disorders targeting the GABAB receptor system, file e2f56ed3-b4a7-3eaf-e053-3a05fe0a5d97
|
1
|
|
Baclofen suppresses alcohol intake and craving for alcohol in a schizophrenic alcohol-dependent patient. A case report, file e2f56ed3-c49e-3eaf-e053-3a05fe0a5d97
|
1
|
|
null, file e2f56ed3-c8ff-3eaf-e053-3a05fe0a5d97
|
1
|
|
Effectiveness and safety of medications used to treat alcohol use disorder in women, file e2f56ed4-0169-3eaf-e053-3a05fe0a5d97
|
1
|
|
La dipendenza da cibo: il binge eating disorder, file e2f56ed5-84c6-3eaf-e053-3a05fe0a5d97
|
1
|
|
Report del progetto di Ricerca dal titolo:
I costi delle dipendenze: aspetti economico-sanitari delle politiche di settore in Sardegna, file e2f56ed5-942a-3eaf-e053-3a05fe0a5d97
|
1
|
|
Consumo moderato di alcol: effetto protettivo?, file e2f56ed7-8bb9-3eaf-e053-3a05fe0a5d97
|
1
|
|
Efficacia dei farmaci per l’alcolismo: il ruolo della genetica, file e2f56ed7-d478-3eaf-e053-3a05fe0a5d97
|
1
|
|
Naltrexone nel trattamento del disturbo da uso di alcol: effetti collaterali e interazioni, file e2f56ed7-e6c6-3eaf-e053-3a05fe0a5d97
|
1
|
|
Cannabis terapeutica: quali vie di somministrazione?, file e2f56ed8-50b7-3eaf-e053-3a05fe0a5d97
|
1
|
|
Sex differences in the response to opioids for pain relief: A systematic review and meta-analysis, file e2f56ed9-2648-3eaf-e053-3a05fe0a5d97
|
1
|
|
Risk of thiamine deficiency and Wernicke's encephalopathy after gastrointestinal surgery for cancer, file e2f56ed9-d25d-3eaf-e053-3a05fe0a5d97
|
1
|
|
The Xs and Y response to opioids in acute and chronic pain, file e2f56eda-0814-3eaf-e053-3a05fe0a5d97
|
1
|
|
null, file e2f56eda-3427-3eaf-e053-3a05fe0a5d97
|
1
|
|
Alcohol consumption is a modifiable risk factor for breast cancer: Are women aware of this relationship?, file e34d93c6-50d4-4435-a696-6eaec5d619fb
|
1
|
| Totale |
3.412 |